Most Recent
Novartis has applied to amend its proposed patent for an oral form of multiple sclerosis drug Gilenya, as it appeals an invalidity ruling by IP Australia for lack of inventive step.
The potential source of alleged "industrial espionage” in Motorola’s case against Hytera over the intellectual property for its digital radio mobile devices has been revealed as a mystery woman with two laptops that contained a “very large number of Motorola documents”, a court has heard.
Motorola has slammed Hytera for engaging in “industrial espionage on a grand scale”, after more than a thousand Motorola-branded documents were found in the possession of the Chinese radio maker.
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy's Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.